← the 2026-10-26 wrap
SPY · 2026-10-26 · weekly change

ALLE

Allegion plc

covered 8 times →
+14.66%
Bullish
Catalyst

Q3 2026 adjusted EPS of $2.60 beat consensus and raised 2026 EPS guidance to $9.05-9.10, sending the stock up 11.02% on 22 October.

Allegion plc is an Industrials company in security products that sells door controls, locks, exit devices, key systems, electronic security and access control systems, plus related services and software.

Price history

PriceS&P 500 (indexed)

Key facts

Close, 2026-10-26
$178.22
5-session move
+14.66%
from $155.44
Session range
$177.10 – $180.41
open $178.91
Volume
1.7m
1.4× 50-day avg
52-week range
$124.05close $178.22, 95% of the range$181.03
50-day avg
$156.48
200-day avg
$149.16
Market cap
$15.16bn
Forward P/E
17.7×
Dividend yield
1.23%
Year to date
+12.03%
Same period · Building Products
  • S&P 500 -0.18%
  • TT -2.15%
  • JCI -0.49%
  • CARR +2.23%
  • LII +2.77%
  • MAS +3.44%
  • AOS +5.50%

Market data from Yahoo Finance at the 2026-10-26 close, computed by the site, not the AI.

Analyst Report: ALLE

1. EXECUTIVE SUMMARY

Allegion rose 14.66% over the week to $178.22, and almost all of the gain came on 22 October, when the stock jumped 11.02% after a third-quarter report that beat consensus and lifted full-year guidance. Adjusted EPS of $2.60 and revenue of $1,172.6m were led by the Americas, and management raised its 2026 adjusted EPS range to $9.05–9.10, above the $8.97 analysts had expected according to TIKR. BofA's upgrade to Buy on 23 October, with a $200 target, added a further 1.39% the next session. The stock sits close to its 52-week high of $181.03, and the next test is whether International volumes recover.

2. THE CATALYST

Allegion released Q3 2026 results on 22 October, and the stock closed that session at $176.52, up 11.02% from $159.00 on volume of 2,097,500 shares.

MetricReportedConsensus
Adjusted EPS$2.60, up 13% (8-K)$2.50 (Seeking Alpha); $2.49 (Zacks)
Revenue$1,172.6m, up 9.6% reported, 7.2% organic (8-K)$1.14bn (Seeking Alpha)
Adjusted operating margin24.7% vs 24.1% a year earlier (8-K)n/a

The Americas segment, about 80% of Q3 sales, grew 9.1% organically, with low-double-digit non-residential growth and mid-single-digit residential growth (TIKR; Zacks). International organic sales fell 0.2% on weak Western Europe, especially Germany, and its adjusted margin dropped 40 bps to 13.9% (Motley Fool transcript; TIKR).

Guidance for 2026 moved up on the Q3 release and call (Investing.com; Benzinga):

ItemNewPrior
Reported revenue growth9.5–10.5%7.5–8.5%
Organic growth5–6%3.5–4.5%
Adjusted EPS$9.05–9.10$8.85–9.00

Americas organic growth is now guided at 7–8%.

On 23 October, BofA Securities (Rafe Jadrosich) upgraded the stock to Buy from Neutral and raised its target to $200 from $164 (Investing.com; TradingView/Benzinga). The stock closed that day at $178.98. Benzinga ties the Friday gain to the earnings, the guidance and the upgrade together. On 26 October the stock slipped 0.42% to $178.22, and no source in the brief explains the dip.

3. COMPANY PROFILE

Allegion plc is an Industrials company in Security & Protection Services, with a market cap of $15.16bn. It operates through Allegion Americas and Allegion International, and sells door controls, exit devices, locks, locksets, key systems, electronic security products and access control systems, along with services and software. Building Products names such as TT, JCI, CARR, LII, MAS and AOS serve as sector comparisons.

Q1 2026 was a weak starting point: adjusted EPS fell 3.2% and organic revenue rose 2.6%, with volume declines offset by price (Allegion 8-K, Q1 2026). In Q3, year-to-date available cash flow was $539.4m, up 11.2% (Motley Fool transcript). The company repurchased about $120m of stock in the quarter and paid about $46m in dividends (TradingView/Zacks). Tariff refunds added $19.9m to reported operating income and are excluded from adjusted EPS (TIKR). The call also mentioned an acquisition of a door company, whose name differs between sources (Overlea in Benzinga, Overly in Motley Fool), so it is left unnamed here.

4. DEEP DIVE ANALYSIS

Do fundamentals justify the move? The beat was broad enough on the Americas side to support a re-rating. Organic Americas growth of 9.1% compares with a guided 7–8% for the year, and management said the full-year outlook matched year-to-date segment growth (Investing.com call transcript). Raised EPS guidance above the $8.97 prior expectation (TIKR) shifted the earnings base, and the stock now trades at 17.7 times forward earnings against 22.2 times trailing.

BofA's raised estimates push further: 2026 EPS up 3% to $9.10, 2027 up 9% to $10.09 and 2028 up 11% to $10.76, with the target multiple lifted to 15.5x 2027 EV/EBITDA from 13.5x (Investing.com). BofA cited accelerating Americas organic growth, improving volume trends and better 2027 visibility (TradingView/Benzinga). Data-center projects were about 5% of Americas non-residential business and growing quickly (Investing.com), and BofA named data-center demand as a support into 2027 (Benzinga).

Precedent. On 23 July, Allegion also raised its full-year outlook, citing Americas non-residential strength and weaker European demand (8-K). The brief does not source the share-price reaction to that report.

Peers. Over the same period TT fell 2.15% and JCI fell 0.49%, while CARR rose 2.23%, LII 2.77%, MAS 3.44% and AOS 5.50%. Allegion's 14.66% gain far exceeds every peer, which points to a company-specific driver. No source explains the peer dispersion.

Bull case. Americas momentum, data-center exposure, buybacks and cash flow growth continue, and the mean FactSet target of $188.30 (MarketScreener) sits above the current price. BofA's $200 target implies further upside.

Bear case. International is shrinking, with Western Europe weak. The CFO expected inflation to stay elevated into next year and signalled another pricing action, though the source sentence is cut off and the timing is unconfirmed (Benzinga). A Seeking Alpha piece dated 27 October argues the Americas upside is already priced in, which is commentary published after the move. MarketScreener lists Morgan Stanley raising its target to $170 from $160 and Evercore ISI cutting to $175 from $180, both single-source and unconfirmed. If accurate, both targets sit below the current price.

5. TECHNICAL SNAPSHOT

The close of $178.22 is 13.9% above the 50-day average of $156.48 and 19.5% above the 200-day average of $149.16, a wide gap created by one gap-up session. It sits $2.81 below the 52-week high of $181.03 set on 12 February and well above the 52-week low of $124.05. Volume on 26 October was 1,664,800, or 1.37x the 50-session average of 1,217,264, and the three sessions since the report have all traded above that average, which shows continued participation after the jump. The nearest support is the 22 October close of $176.52, with the $159.00 pre-report close beneath it. The nearest resistance is the 23 October close of $178.98, followed by the 52-week high.

6. RISK FACTORS

  • International weakness in Western Europe, especially Germany, may extend and weigh on margins, which fell 40 bps to 13.9% last quarter.
  • Persistent inflation and pricing actions could affect volumes, with timing unconfirmed.
  • The valuation has moved after a 14.66% weekly gain, and some post-move commentary says the upside is priced in.
  • Data-center demand is about 5% of Americas non-residential, so it supports the story without carrying it.
  • Analyst targets are mixed: the unconfirmed Morgan Stanley and Evercore targets sit below the share price.
  • Next catalyst: the Q4 2026 report, expected in early 2027 (TIKR). A confirmed date is not available, and the key test is whether International volumes recover.

7. ACTIONABLE OUTLOOK

Short term (1-2 weeks): The stock trades just under its 52-week high after three sessions of elevated volume. A move through $181.03 would set a new 52-week high, and a drop below $176.52 would start to fill the post-earnings gap. No dated catalyst falls in the window.

Medium term (1-3 months): The raised guidance and higher estimates set a new earnings base of $9.05–9.10, and the stock now needs Americas growth of 7–8% to hold. Analyst targets are the main reference: the $188.30 FactSet mean and BofA's $200 sit above the price, while the unconfirmed Morgan Stanley and Evercore figures sit below it.

Long term: The thesis rests on Americas non-residential demand, cash returns and margin expansion, and Q3 strengthened it. International remains the open question, and the Q4 report will show whether volumes there recover. This is analysis only and not personal financial advice.

researched and written by an AI agent · not financial advice